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A B S T R A C T
Cancer is a major health issue and the object of investigations in thousands of laboratories all over the world.
Most of cancer research is being carried out in in vitro systems or in animal models, generally mice or rats.
However, the discovery of the high degree of genetic identity among metazoans has prompted investigation in
organisms like Drosophila, on the idea that the genetic basis of cancer in flies and humans may have many aspects
in common. Moreover, the sophisticated genetic methodology of Drosophila offers operational advantages and
allows experimental approaches inaccessible in other species.
Cell competition is a cell-quality control process that aims to identifying and subsequently removing cells
within animal tissues that are unfit, abnormal or aberrant, and that may compromise the fitness or the viability
of the organism.
It was originally described in Drosophila imaginal discs but later work has shown it occurs in mammalian
tissues where it fulfils similar roles. One aspect of the surveillance role of cell competition is to eliminate on-
cogenic cells that may appear during development or the life of an organism. In this review we have focussed on
the work on Drosophila imaginal discs relating cell competition and tumorigenic processes. We briefly discuss
related work in mammalian tissues.
1. Drosophila and Cancer
The fruitfly Drosophila has been a major object of genetic research
for a long time, since the beginning of the XX century. The entire life
cycle lasts 10–11 days in optimal conditions. After about 24 h of em-
bryonic development, there are three larval stages before pupariation
and metamorphosis, after which the new adult emerges. The larvae
contain inside the precursors of the adult structures, called imaginal
discs, which are named after the particular adult structure, wing, leg,
eye-antenna, etc., they will eventually form. The imaginal discs are
easily identified and genetically manipulated during the larval period
and are a convenient system to study tumour overgrowths [1–3].
Cancer may appear spontaneously in flies [4], but most of the in-
formation about tumorigenesis in Drosophila derives from the identifi-
cation and analysis of a number of genes whose mutations cause tu-
morigenesis (reviewed in [2], Table 1). These mutations are lethal but
allow larval development; the mutant larvae grow very large and
contain big tumour overgrowths, usually affecting the imaginal discs
and the nervous system.
Those genes are usually referred to as tumour-suppressing genes (TSG)
based on that their loss of function causes tumour development.
However, they are involved with a number of biological processes, e.g.
apico-basal polarity, endocytosis, cell identity, etc. not directly related
with growth control. How defects in these processes cause tumorigen-
esis is not entirely clear; it is likely that it is a secondary consequence of
the principal defect.
The number of TSGs is large (see Flybase, https://www.sdbonline.
org/sites/fly/aignfam/tumorsup.htm), thus in this review we will
consider some whose mutations cause neoplastic transformations and in
which cell competition has been shown to play a role. We will discuss
results obtained with lethal giant larvae (lgl), scribble (scrib), erupted
(ept), Rab5 and polyhomeotic (ph). Their tumorigenic effect has been
characterised in the imaginal discs, usually the eye or the wing disc.
A significant feature of the TSG mutant cells is that, unlike normal
cells, they can proliferate indefinitely. The proliferation rate is not
higher than in normal cells but the mutant cells remain proliferating
indefinitely until the larva dies [5–7]. This feature of not responding to
stop growth signals is one of the distinctive tumorigenic features.
A detailed study of the morphological and developmental altera-
tions of homozygous larvae and discs mutant for TSGs is still lacking,
but a common feature of lgl, rab5 and erupted discs is that they show
high levels of apoptosis and of JNK activity [7]; Calleja, unpublished),
although their involvement of these factors in the development of the
tumours not been studied. One of the known targets of JNK is the
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Matrix metalloprotease 1 (Mmp1), involved in breakdown of the ex-
tracellular matrix, thus favouring cell invasion and possibly metastasis.
In the case of the lgl mutant larvae, we have shown that Mmp1 is re-
quired for the fusion of imaginal discs [7].
2. Cell competition
Cell interactions are widespread in animal tissues and play key roles
in processes like pattern formation, morphogenesis and cell differ-
entiation. Among those, cell competition (CC) is a special kind of
cell–cell interaction that plays an important role in tissue homeostasis
by removing unfit or undesirable cells.
Animal tissues usually contain millions of cells, making it inevitable
the appearance of unfit/abnormal/aberrant cells generated by somatic
mutation [8] or other causes (reviewed in [3]. This calls for the ex-
istence of a mechanism to remove those cells that are not appropriate
for the resident tissue and that may compromise the fitness or the
survival of the organism.
The cell competition (CC) phenomenon fits the above description; it
is a cell-quality control mechanism responsible for the elimination of
cells that are weaker or are not well integrated within the population. It
was originally reported in the wing disc of Drosophila [9] when in-
vestigating the proliferation rate of cells lacking one dose of a Minute
gene. The Minute genes constitute a class of genes encoding ribosomal
proteins [10]. Flies with only one dose of Minute are viable but show
retarded development, likely due to reduction in protein synthesis [11].
The key observation was that viable but slow proliferating cells het-
erozygous for a Minute mutation were eliminated by interactions with
more rapidly dividing neighbours.
Later work extended this phenomenon to other situations; viable
cells with low levels of dMyc (the Drosophila homolog of the mamma-
lian oncogene Myc) or with low activity of the insulin pathway are
eliminated when surrounded by cells with higher dMyc or metabolic
activity [12,13]. Interestingly, cells with wildtype levels of dMyc are
eliminated when confronting others with higher dMyc activity [14,15].
This phenomenon, termed “supercompetition”, reflects the context-de-
pendence nature of cell competition. Moreover, the fact that higher
levels of dMyc generate overproliferation may suggest that super-
competition might be implicated in tumorigenic processes [14–16]. The
phenomenon of CC is not limited to developing imaginal discs; recent
work from the Piddini group has shown the elimination by apoptosis of
sub-optimal cells in the adult intestine [17].
Thus CC describes interactions between two types of viable cells,
nowadays referred to as winner and loser, which result in the elim-
ination of the loser. The key aspect of CC is that it is a context-de-
pendant phenomenon: loser cells are themselves viable; it is just their
interaction with the winners what causes their demise [18].
The role of CC is not only limited to remove unfit or less metabo-
lically active cells; it also includes cells that, due to incorrect levels of
developmental signals [19] or mutations at identity genes [20], are
incorrectly specified within the resident tissue. This phenomenon was
originally called “morphogenetic apoptosis” and is linked to CC [19]. It
is thought to function to ensure the uniform developmental specifica-
tion of cell populations. The interest of these observations is that they
indicate that CC has a function broader than just eliminating unfit or
suboptimal cells; it also disposes of cells that may be fit or metabolically
active, but that are undesirable for the tissue. This point is relevant
when describing the behaviour of oncogenic cells (see below).
A major feature of CC is that it appears to function at short range;
the winner/loser cells have to be very close [18,21,22], possibly in
physical contact. Another important feature, which is often neglected,
is that it occurs between cells that belong to the same identity group.
This is especially clear in the wing disc, which is subdivided into an
anterior (A) and a posterior (P) compartment: CC does not take place
across the A/P border [18], even though A and P compartment cells
abut along the border. Presumably, the different identities of A and P
cells prevent the cell competition interaction. The role in CC of prop-
erties associated with cell identity, e.g. cell affinity, cell adhesion, has
not been investigated.
Although all the original work was carried out in Drosophila, there is
now evidence that CC also functions in mammalian tissues. The mouse
Bst mutation behaves as a Minute mutation in Drosophila [23]; it is vi-
able in heterozygous condition but the mutant cells have growth dis-
advantage when surrounded by normal cells. Furthermore [24], re-
ported that during rat liver regeneration transplanted fetal hepatocytes
are able to out compete resident hepatocytes; a phenomenon akin to
cell competition.
Moreover, there is strong evidence for CC in mouse development
[25,26], demonstrating that during early embryogenesis cells with low
levels ofMyc are eliminated by interaction with neighbours with higher
levels. The removal of these less metabolically active cells is thought to
have a positive effect on the fitness of the organism.
A very recent report [27] describes a morphogenetic function of CC
during mouse skin development. In the early embryonic stage, slow
dividing progenitors (contain lower levels of Mycn) are eliminated by
apoptosis and subsequent engulfment by neighbours with higher pro-
liferation rate. When cell competition is abrogated the stratified struc-
ture of the skin becomes abnormal, an indication of the functional re-
levance of cell competition in normal development.
In conclusion, CC fulfils a general homeostatic role in animal tissues by
eliminating viable cells with are undesirable for the resident tissue; they
may be less fit or weaker than surrounding cells or may have develop-
mental features that are different from those of the general population.
Table 1
A sample of Drosophila genes and their human homologs whose mutations are
associated with tumour transformations both in humans and in flies. These
genes are implicated in a variety of functions, as indicated in the Table. It is not
clear how the defects in any of these functions are translated into a tumorigenic
transformation.
function D.m. genes human genes References
Cell signaling hh Shh/Dhh/Ihh Lin et al., 2016





Insulin Pten PTEN Li et al., 1997
tsc1 TSC1 Pan et al., 2004
gigas TSC2 Pan et al., 2004
Size control Hippo Hippo Harvey et al., 2013
sav hSAV1 Luo et al., 2011
wts(lats) LATS1 (h-warts)
LATS2/(HsLATS2)
Deng et al., 2017/Luo
et al., 2014
Brat TRIM3 Chen et al., 2014
Endocytosis avl* STX7 Strömberg et al.,
2009
Rab5* RAB5 Igarashi et al., 2017
vps25* VPS25 Menut et al 2007
ept* TSG101 Xu And Zheng et al.,
2019
snr1 SMARCB1 Pawel et al., 2018
Cell polarity scrib* hScrib Ouyang et al., 2010
dlg* hDlg1/2/3/4 Mori et al., 1998/
l(2)gl* Hugl1/2 Russ et al., 2012
Notch signalling N N Nowell and Radtke,
2017
Polycomb ph PHC1 Martinez et al., 2009
l(3)mbt L3MBT1 Koga et al., 1999
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3. Cell competition and cancer
One especially interesting role of CC is its function as a tumour
suppressor mechanism: the removal of malignant/oncogenic cells that
may appear during development or the adult life of the organism.
The link between CC and tumorigenesis has been explored by
planting in normal tissues isolated oncogenic cells surrounded by
normal cells, a situation that mimics the appearance of tumours in
mammals. In Drosophila this can be achieved by using recombination
techniques [28,29] to generate clones of mutant cells for TSGs.
These clones of oncogenic cells are appropriately labelled and can
be distinguished from surrounding normal tissue. This is a type of ex-
periment that can easily be done in Drosophila and that allows the study
of the early phases of tumorigenesis, an aspect of the process not easily
attained in mammalian systems. Most of the experiments have been
carried out in the wing or the eye disc. Typically they consist of gen-
erating marked mutant clones for one TSG (lgl, scrib, dlg, rab5, erupted,
etc) [6,30–33] during the larval period and then examining the fate and
behaviour of the clones several days after clone induction. The general
result is that the oncogenic clones are eliminated 48–72 h after clone
initiation (Fig. 2a). As the cells are themselves viable (homozygous
mutant larvae develop extensive tumours), their elimination must result
from interaction with non-tumour cells, a cell competition scenario. The
elimination of oncogenic cells occurs even if they contain high levels of
the Ras pathway provided the rasV12 transgene [34], which confer cell
proliferation or metabolic levels higher than surrounding normal cells:
isolated lgl− rasV12 or rab5- rasV12 clones are eliminated for the tissue
[6,33]. Apparent exceptions to this rule will be discussed in the next
section.
The conclusion for the preceding is that in Drosophila CC functions
as a robust tumour-suppressing mechanism able to remove oncogenic
cells even if they are physiologically more vigorous that the sur-
rounding normal ones. Thus in a cell competition assay oncogenic cells
behave as losers.
An observation of interest is that oncogenic cells are not eliminated
in mosaic discs in which, for example, the anterior compartment is
normal but the posterior compartment is entirely mutant for lgl or scrib
[6] Fig. 2b. Normal and oncogenic cells are abutting along the A/P
border and yet there is no CC. It is a clear demonstration that there is no
CC across compartment borders, suggesting that the different identities
of the A and P compartment cells prevent the CC interaction, possibly
because of the differences in cell affinities.
Differences in cell affinities may also be an explanation for the be-
haviour of clones of cells mutant for polyhomeotics (ph), a member of
the Polycomb group of genes [35–37], involved in the maintenance of
cell identity during development. Unlike mutant cells for the other TSGs
investigated, ph clones survive surrounded by non-mutant cells and
often form large tumorous overgrowths. Nevertheless, these clones
exhibit some special features: while normal clones are usually elon-
gated and integrate with surrounding tissue, ph− clones are usually
round and tend to segregate from the normal tissue, growing separately
(Fig. 3). It is possible that ph− clones acquire cell affinities very dif-
ferent from those of the surrounding cells, in effect preventing the cell-
cell interaction necessary for cell competition.
The tumour-suppressing function of CC appears to extend to mam-
malian tissues. Cells mutant for the mammalian homolog of the
Drosophila scrib gene have been shown to enter apoptosis in cell cultures
when surrounded by normal cells, but not when cultured alone [38], a
typical CC scenario. The Fujita group [39] has also shown that trans-
formed epithelial cells are outcompeted by normal epithelial cells and
are eliminated from the tissue, revealing a tumour suppressing function
that they have termed EDAC (Epithelial Defence Against Cancer).
Work from the Martins group [40] provided a significant observa-
tion suggesting that CC may have a tumour suppressing function in
mammalian tissues in vivo. During the generation of mature T cells in
the mouse thymus there is a continuous replacement of resident
thymocytes by new progenitors coming from the bone marrow. The
newcomers appear to be more successful in competing for interleukin-7,
which results in the death of the old residents. Martins [40] have shown
that the suppression of the influx of new progenitors, and hence of CC,
results in indefinite proliferation of the old thymocytes and the ap-
pearance of lymphoblastic leukaemia.
Another example of elimination of potentially overgrowing tissue by
a mechanism akin to cell competition has been recently reported [41].
These authors generate in the mouse hair follicle epithelium cells with
an activated form of ß-catenin and observe the formation of outgrowths
that are nevertheless promptly eliminated by apoptosis after interaction
with neighbour wildtype cells. They obtain a similar result after gen-
erating cells containing an oncogenic form of Ras; after an initial
overgrowth caused by mutant cells, the follicle returns for normal,
presumably because the oncogenic cells have been eliminated.
Considering together the observations from Drosophila and mam-
malian tissues, the general suggestion is that CC encodes a tumour
suppressing function present in all metazoans.
4. Cell competition, JNK and apoptosis
There are two major events in the molecular mechanism of CC, 1)
the initial comparison between cells, which determines the winner or
the loser status, and 2) the activation of the death program in the loser
cell.
The mechanism of the cell–cell comparison remains largely un-
known. Since cell competition is a short-range phenomenon that may
require physical contact, it is likely that it involves comparison of
molecules at the cell membranes. One first consequence of the com-
parison appears to be the modification of the transcriptional activity of
the flower gene, which encodes a trans-membrane protein [42,43].
There are three different forms of the Flower product, FlowerUbi,
FlowerLoseA and FlowerLoseB. While FlowerUbi is expressed in all cells of
the disc, FlowerLoseA and FlowerLoseB appear are expressed only in loser
cells. The two Lose forms are directly implicated in the process, for their
suppression by RNA interference prevents the elimination of the loser
cells [43].
The second event, i.e. the activation of the death program by the
loser cells is better known, though not completely resolved. Work from
the Moreno group has identified the gene azot, that encodes calcium
binding protein, as necessary for the elimination of the loser cells [44],
but the mechanism by which azot intervenes in the process has not yet
been established.
An appealing proposal [45,46] implicates the signalling Spz/Toll
module of the innate immune system. Winner cells activate the release
of the Spz ligand that acts as a death signal in neighbour loser cells. The
process requires Toll and Toll-8 receptors and eventually leads to the
activation of pro-apoptotic genes hid o reaper. Inhibition of Toll activity
results in rescue of loser cells. However, the role of Toll in cell com-
petition has been questioned by recent work [47] showing that in
axenic (free of pathogens) flies Toll inhibition (by overexpressing
Cactus) fails to rescue loser cells in a Minute cell competition scenario.
These observations suggest that the effect of Toll on cell competition
might be a consequence of its proliferative response to infection.
The first indication of the link between cell competition and the cell
death program was reported by Moreno [48] in experiments in the wing
disc. Loser Minute heterozygous cells are eliminated by programmed
cell death (apoptosis), triggered by the activation of the Jun N-Terminal
Kinase (JNK) pathway, the principal stress response factor in Droso-
phila. Later work has shown that the pro-apoptotic role of JNK is re-
quired for the elimination of loser cells in many different cell compe-
tition assays, including the elimination of oncogenic cells thus
underlying the pivotal role of JNK in CC.
A simplified scheme of the apoptosis program and the position of
JNK therein are shown in Fig. 1. JNK exerts autocrine (cell autono-
mous) pro-apoptotic role and a paracrine (non-cell autonomous) pro-
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proliferation function. The paracrine cell proliferation stimulating
function of JNK has tumorigenic consequences in certain conditions
(see below).
Oncogenic cells normally behave as losers in a CC assay. They ex-
press JNK activity previous to their death [6,30,33,49,50] and follow
the rules described for Minute CC: activation of the JNK pathway fol-
lowed by induction of pro-apoptotic genes and subsequently activation
of caspases, which results in the death of the cells (Fig. 2a). Im-
portantly, the pro-apoptotic function of JNK is critical for the process,
for in its absence oncogenic lgl− or scrib− mutant cells survive [6,51].
Thus the tumour-suppressing role of CC relies on the autocrine function
of JNK: oncogenic cells trigger their own demise endogenously acti-
vating the JNK-mediated apoptosis program.
A relevant question is how the JNK is activated in the loser cells.
Fig. 1. Simplified scheme of the apoptosis
program of Drosophila and the role of JNK in it.
Cells expressing JNK activate the function of
pro-apoptotic genes, collectively referred to as
RHG (for reaper, hid and grim, the principal
pro-apoptotic genes) that block the function of
the inhibitor of apoptosis diap (the Drosophila
inhibitor of apoptosis gene), thus allowing the
activation of the apical caspase Dronc and
subsequently of the effector caspases Drice and
Dcp1 direct responsible for the death of the
cell. This reflects the autocrine cell autono-
mous pro-apoptotic function of JNK. Note that
Dronc not only activates Drice and Dcp1 but it
also further stimulates JNK activity, thus gen-
erating an amplification of the apoptotic levels
(Shelkvov and Morata, 2012).
Dying JNK-expressing cells secrete mitogens
like Wg, Dpp or Unpaired [64,65,68] that sti-
mulate the proliferation of neighbour cells (il-
lustrated in the upper right side of the figure).
This paracrine JNK activity is involved in some
tumorigenic processes in Drosophila. Note that JNK triggers its own feedback loop via the function of the target moladietz (mol), which stimulates the production of
Reactive Oxygen Species (ROS), known to induce JNK (see [51], for a more detailed description). In the majority of the situations cells expressing JNK are short-lived
and the paracrine effect is negligible, but when death is delayed or the death machinery is defective the paracrine effect may become predominant.
Fig. 2. Distinct behaviour of scrib− cells when
surrounded by no-tumour cells (a) or when an
entire compartment is scrib− (b). The scrib−
clone (GFP) in a (magnified in the panel on the
right) is being eliminated by cell competition;
many cells express the Matrix metalloprotease
1, Mmp1 (red), a JNK target and express the
effector caspase Dcp1 (blue). In b there is the
comparison of a wildtype posterior compart-
ment (hh > GFP) with a posterior compart-
ment mutant for scrib. Although the scrib−
compartment contains high levels of Mmp1
and Dcp1 it still overgrowths reaching a larger
size that a normal posterior compartment.
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This issue is being intensively investigated in recent years. Some genes
of interest have been found by the Igaki group after a screen designed to
isolate candidate genes required for the elimination of mutant cells for
the oncogenic mutations scribble (scrib) or disc large (dlg). They found
that the loss of function of the gene stranded at second (sas), which
encodes a ligand protein necessary for axon guidance [52], in winner
cells prevents the death of scrib− loser cells. Moreover, they also
identified a specific receptor molecule, PTP10D, which is required in
the losers [50]. As a result of the winner/loser interaction, winner cells
relocalise the Sas ligand from the apical to the lateral surface of the
cells, and the losers relocalise the PTP10D receptor to the same posi-
tion, thus triggering activation of PTP10D signalling. This causes down
regulation of EGFR activity and in turn up regulation of JNK and sub-
sequent apoptosis of loser cells [50]. A similar process occurs during the
elimination of mutant cells for vps25, ept or rab5. However, as the au-
thors point out, this mechanism does not appear to function in other
cases of cell competition triggered by alteration of Minute or of dMyc
levels, raising the possibility that it is specific for elimination of onco-
genic cells.
Another factor involved is the secreted protein Serpin5 (Spn5), also
necessary to remove scrib− or dlg− oncogenic cells [53]. Spn5 is se-
creted by normal epithelial cells and blocks Toll signalling in the on-
cogenic cells (Ahmad et al., 2019 PNAS), what eventually results in
their elimination by the autocrine function of JNK. The functional
connection between Sas/PTP10D and Spn5/Toll has not been estab-
lished.
An interesting observation has been reported by Kucinski [54],
pointing out thatMinute and mahjong cell competition is associated with
oxidative stress in the loser cells, as indicated by overexpression of
Nrf2, a major transcription factor involved in the response to oxidative
stress. Moreover, we have recently reported a related observation [51]:
scrib− loser clones express high levels of Reactive Oxygen Species (ROS)
during the whole time that clones remain alive, about 72 h, also sug-
gesting that oxidative stress is involved in losers elimination.
Since high ROS levels are known to activate JNK [55–59] these
findings point out to another possible mechanism of JNK activation
based on the idea that the presence of scrib− (or Minute or mahjong)
cells may be interpreted as a local stress by the surrounding issue. JNK
activation by ROS may become permanent in the cells, for JNK is
known to induce the function of the DUAL maturation factor moladietz
(mol) that in turn stimulates ROS production, generating a feedback
loop [60,61]; see Fig. 1) that maintains JNK activity until the demise of
the loser cells. The fact that oxidative stress in loser cells has been
shown in at least two different CC scenarios (Minute and mahjong/scrib)
suggests that it may be a general feature in the elimination of loser cells.
At this moment there is not an unified model of JNK activation in
loser cells that would incorporate the different factors involved, e.g.
Flower, azot, Spz/Toll, Sas/PTP10, Serpin5, ROS. There is also the
possibility that different modes of CC may induce JNK by distinct me-
chanisms.
5. Incomplete cell competition promotes tumorigenesis
Even though cell competition exerts a robust anti-tumour function,
there are situations in which tumour cells evade cell competition and
proceed to form an invasive tumour. As mentioned above, cells mutant
for lgl, scrib or rab5 are normally eliminated by CC, even if by over-
expression of the Ras pathway they have higher proliferation rate than
surrounding non-mutant cells [6].
However, we and others [6,32,62,63] reported that discs containing
numerous lgl− rasV12 (or scrib− ras V12 or rab5 ras V12) clones form large
patches of mutant tissue that colonise the entire discs (Fig. 4). However,
a detailed study of this finding [6] showed that only discs containing
high density of clones were able to form tumour overgrowths; discs
with low density failed to produce them. In the latter case the few
clones found were small and with many cells in apoptosis.
Based on these results we argued that the failure of cell competition
to prevent tumour overgrowths in discs containing numerous clones
was due to the merging of neighbour clones. The merging results in
large patches of mutant tissue in which many of the inner cells of the
patch are beyond the reach of cell competition, which is a short-range
phenomenon [21,22]). This group protection mechanism allows tu-
mour cells inside the group to continue proliferating. A scheme of the
model is presented in Fig. 4.
Evidence for this mechanism was provided using cells deficient for
rab5 activity: isolated rab5 deficient cells are eliminated, but when a
group of about 400–500 cells are simultaneously transformed from
normal to oncogenic, they survive and develop a tumour outgrowth
[33]. It is worth emphasising that cell competition is not abrogated in
these conditions; it is restricted to the border of the patches, where the
winner/loser interactions take place, as indicated by localisation of cells
in apoptosis (illustrated in Fig. 5, see also Fig. 4). A significant fact is
that there is continuous turn over of loser cells at the border, as new
rab5 cells replace the dead losers. This causes persistent apoptosis, ac-
companied by persistent JNK activity. Under these conditions the
continuous activity of JNK in dying cells results in continuous secretion
of mitogenic signals [64,65], what stimulates the proliferation of the
tumour cells.
A significant finding from these experiments is that the development
of the rab5 tumour outgrowths depends on JNK: in its absence rab5
deficient cells are not eliminated but remain idle and do no over-pro-
liferate [33]. This is a reversal of the normal anti-tumour role of JNK
mentioned above and indicates that when CC is not completely effec-
tive, the paracrine effect of JNK will stimulate tumour growth
Fig. 3. Comparison of the size and shape of
wildtype (a) and polyhomeotic (b) clones in the
wing disc. Both sets of clones were induced
72 h before fixation. Note that some of the
polyhomeotic clones are noticeably larger than
the wildtype clones and also exhibit very dif-
ferent shape; they tend to be round, showing
little indication of interaction cells and in-
tegration with the surrounding tissue. In cases
they appear to sort out from the disc, like the
big clone at the left hand side.
G. Morata and M. Calleja Seminars in Cancer Biology xxx (xxxx) xxx–xxx
5
The fact that rab5 cells can only form a tumour when in a suffi-
ciently large group, may prompt the speculation whether some human
cancers may also originate not by individual clones by polyclones in
which some cells escape the control mechanisms like CC or others. This
kind of mechanism could play a role in the establishment of tumorous
growths associated with persistent injuries like for example gastric ul-
cers. Caused by an infection of Helicobacter pylori, they are associated
with inflammation, contain many cells in apoptosis and frequently
develop into gastric cancer (reviewed in [66]. It has been shown that
mammalian cells in apoptosis secrete proliferative signals [67], and the
persistent apoptosis in situations like the gastric ulcer may be a con-
tributing factor in the appearance of the cancer.
6. Both the tumour-suppressing and the tumour-stimulating
functions of cell competition are mediated by JNK activity
A prime feature of CC is the cell autonomous activation of the JNK
pathway in the loser cells that in the majority of the situations leads to
their elimination by apoptosis. Thus JNK is the molecular tool used by
CC to culling viable but weak, damaged or malignant cells that may
appear in animal tissues.
However, JNK is also able to exert a paracrine pro-proliferation
function: dying JNK-expressing (loser) cells secrete mitogenic signals
that stimulate the proliferation of neighbour cells [64,65], Fig. 1). The
paracrine function is inherent to JNK-expressing cells (Fig. 1), but it is
normally inconsequential because cells in apoptosis are short-lived.
Nevertheless, the removal of oncogenic cells by CC usually takes 2–3
days [6,33], a period during which the cells maintain JNK activity and
hence keep secreting mitogenic signals. This result raises the possibility
that the paracrine function of JNK may be responsible for the pro-
liferation stimulus of winner cells after the CC interaction [14,15]. The
finding that tumour overgrowths associated with oncogenic mutations
and Ras overexpression [68] requires JNK activity supports this view.
Finally, as mentioned above, the pro-proliferative signalling emanating
from JNK-expressing cells is also responsible for the tumorous over-
growths found when CC is made ineffective by the group protection
mechanism.
The tumour-stimulating activity of the paracrine JNK function be-
comes evident when the autocrine activity is made ineffective by sup-
pressing the apoptotic machinery [51,61]. In apoptosis-defective cells a
transient induction of JNK, by X-radiation or a pulse of P53, is
Fig. 4. Wing disc containing large patches of lgl− rasV12 tissue labelled with GFP that colonise the disc almost entirely. Note the high levels of Caspase activity (red) in
the border of the patches and that the dying cells belong to the lgl− rasV12 tissue (arrows).
Fig. 5. Scheme of the group protection model of tumorigenesis. Tumour cells
are in red, non-tumour ones in pink. Cell nuclei in blue. Because cell compe-
tition is a short-range phenomenon tumour cells inside the group are beyond
the reach of cell competition; only those at the border interact with non-tumour
cells and die by JNK-mediated apoptosis. In the figure they are represented as
those with fragmented nuclei. The dying JNK-expressing cells secrete pro-
liferative signals, indicated by the yellow arrows. The signalling emanating
from the dying cells can affect cells located either inside or outside the patch.
Those inside are tumour cells that are stimulated to divide and contribute to the
growth of the tumour. Note that because of the nature of the interaction, once
the loser cells at the border are been eliminated, they will be eventually re-
placed by new ones the resume the interaction.
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translated into persistent JNK activity, which in turn induces the
function of the JAK/STAT and Wg and Dpp pathways. The actual me-
chanism(s) by which these signalling pathways stimulate proliferation
is not completely resolved, but the important fact is that JNK has the
property of perpetuating its function through a feedback amplification
loop that involves ROS and the dual maturation factor moladietz (mol)
[61]. This amplification loop was first reported by Khan et al., 2107
when describing the persistence of JNK activity during regeneration of
the wing disc.
The two apparently contradictory functions of JNK, pro-apoptotic
(anti-tumour) and pro-cell proliferation (tumorigenic), have also been
observed in mammalian tissues (reviewed in [69]). Moreover, sustained
and elevated levels of JNK activity have been observed in hepatocel-
lular carcinomas both in mice and in human patients [70,71]. It is
possible that the some of the mechanisms responsible for tumour
overgrowths in Drosophila may also apply to human patients.
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